Results 111 to 120 of about 2,798,242 (291)

DIFFUSE AXONAL SWELLINGS IN A CASE OF ACQUIRED IMMUNODEFICIENCY SYNDROME

open access: yes, 1988
We report a case of a 25-year-old woman affected by the acquired immunodeficiency syndrome in whom the neuropathologic examination disclosed the presence of diffuse axonal swellings in the brain stem and in selected areas of cerebral hemispheres.
GIANGASPERO, FELICE, M. P. Foschini
core  

Human immunodeficiency virus/acquired immunodeficiency syndrome education in schools

open access: yes, 1998
The human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) epidemic has grown during the past 15 years. Education remains a critical component of our efforts to prevent HIV infection/AIDS in school children and young adults.
Comm Pediat AIDS   +5 more
core   +1 more source

Associations of cannabis use, tobacco use and co‐use with brain volume: A systematic review and meta‐analysis

open access: yesAddiction, EarlyView.
Abstract Background and aims Cannabis is the most widely used illicit drug worldwide and is often co‐used with tobacco, the leading cause of preventable death. Although cannabis and tobacco have distinct neurobiological actions, their associations with brain volumes are unclear.
Katherine Sawyer   +16 more
wiley   +1 more source

Disseminated aspergillosis in the acquired immunodeficiency syndrome

open access: yes, 1994
The relationship of disseminated aspergillosis with human immunodeficiency virus (HIV) infection is unclear. In the initial case definition of acquired immunodeficiency syndrome (AIDS) developed by the Centres for Disease Control (CDC), Atlanta ...
Wijesurendra, C. S.   +2 more
core   +1 more source

Mesenchymal Stem Cells From a Klinefelter Syndrome Patient: Functional Characterization and Therapeutic Implications

open access: yesAndrology, EarlyView.
ABSTRACT Background Cell therapy, particularly those utilizing mesenchymal stem/stromal cells (MSCs), is gaining traction as a therapeutic option for regenerative treatment in patients with limited therapeutic options. Although the safety of MSC‐based interventions is well established, uncertainties remain regarding how genetic abnormalities and ...
Marzena Zychowicz   +12 more
wiley   +1 more source

Social representations of imprisoned women on Acquired Immunodeficiency Syndrome

open access: yes, 2018
Objective: to understand the social representations of imprisoned women on Acquired Immunodeficiency Syndrome. Methods: qualitative study conducted with 32 women imprisoned in a rehabilitation center.
Pinho, Tatyana Ataíde Melo de   +7 more
core   +1 more source

Neuropsychiatric‐Led Presentation of Late‐Onset Parkin‐Related Parkinson's Disease

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Sarah Fullam   +4 more
wiley   +1 more source

Hypogonadism in Cisgender Men Living With HIV: Prevalence, Clinical and Metabolic Features

open access: yesAndrology, EarlyView.
ABSTRACT Background Hypogonadism is frequently observed in men living with human immunodeficiency virus (HIV), although its prevalence, etiology, and predictors remain incompletely understood. Objective To evaluate the prevalence of hypogonadism and its association with metabolic factors in men living with HIV (MLWH), on stable antiretroviral therapy ...
Felipe Augusto Azevedo Leao   +8 more
wiley   +1 more source

Behavior of sexually transmitted infections in adolescents

open access: yesActa Médica del Centro, 2014
Studies made at the global level in Cuba on sexually transmitted infections and acquired immunodeficiency syndrome in adolescence demonstrate the need for comprehensive care for all sectors of society to achieve physical, mental and social balance of ...
Lidia Pérez Morffi   +2 more
doaj  

Cryptococcal Optic Neuropathy in the Acquired Immunodeficiency Syndrome

open access: yes, 1990
The acquired immunodeficiency syndrome (AIDS) is associated with a variety of ophthalmic manifestations. Neuro-ophthalmic pathology is often secondary to opportunistic infections. C. neoformans is one of the more common fungal agents.
Karl C. Golnik, MD
core  

Home - About - Disclaimer - Privacy